Thursday, February 7, 2013
If You Have Diabetes, Would You Rather Have Bypass Surgery or Chelation Therapy?
The New England Journal of Medicine had a recent article comparing angioplasty with stents to bypass surgery (CABG) for patients with diabetes and vascular disease. The end points were a composite of death from any cause, nonfatal heart attack, and nonfatal stroke. Conventional medical therapy was continued as well. The study showed that CABG had fewer deaths and heart attacks but more strokes. These end points were included in the Trial to Assess Chelation Therapy (TACT), and those patients who were given EDTA chelation therapy had significantly fewer cardiac events. Diabetic patients with vascular disease did better than the rest of the patients. I believe it would save lives and improve the quality of life for patients at risk if the TACT results were promptly put into the accepted practice of medicine. The experience of our clinic over the last 30 years has shown that all vascular patients, including diabetics, do very well with chelation therapy, even when other therapies have not been effective. See ME Farhouh and associates. N Engl J Med 2012; 367:2375-2384. Contact Dr. Chappell's office healthcelebration.com for more info on chelation therapy.